(Iso)-Dehydroemetine

CAS No. 2649-50-5

(Iso)-Dehydroemetine( —— )

Catalog No. M36071 CAS No. 2649-50-5

(Iso)-Dehydroemetine (Dehydroisoemetine, (+/-)-) is a compound with antispasmolytic effect on smooth muscle.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 340 Get Quote
5MG 273 Get Quote
10MG 372 Get Quote
25MG 563 Get Quote
50MG 742 Get Quote
100MG 977 Get Quote
200MG 1293 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (Iso)-Dehydroemetine
  • Note
    Research use only, not for human use.
  • Brief Description
    (Iso)-Dehydroemetine (Dehydroisoemetine, (+/-)-) is a compound with antispasmolytic effect on smooth muscle.
  • Description
    (Iso)-Dehydroemetine (Dehydroisoemetine, (+/-)-) is a compound with antispasmolytic effect on smooth muscle.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2649-50-5
  • Formula Weight
    478.62
  • Molecular Formula
    C29H38N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C=1C[C@]2(C=3C(=CC(OC)=C(OC)C3)CCN2CC1CC)[H])[C@H]4C=5C(=CC(OC)=C(OC)C5)CCN4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Butin

    Butin is a major biologically active flavonoid isolated from the heartwood of Dalbergia odorifera with oral activity, with strong antioxidant, antiplatelet and anti-inflammatory activities. Butin significantly alleviates myocardial infarction and improves heart function, together with prevents diabetes-induced cardiac oxidative damage in rat.

  • Eptifibatide acetate

    Eptifibatide an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue.

  • MSC-4106

    MSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model .